Intrinsic value of Lazard US Equity Concentrated Portfolio Open Shares (LEVOX)
Live fair value data for Lazard US Equity Concentrated Portfolio Open Shares (LEVOX) is currently unavailable. Please check again shortly.
Current Price: $198.00
Valuation: Overvalued
Confidence: 4.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Lazard US Equity Concentrated Portfolio Open Shares (LEVOX) undervalued or overvalued?
Based on the current model output, Lazard US Equity Concentrated Portfolio Open Shares appears to be overvalued with a downside of 9.00%.
Fair value vs market price — Lazard US Equity Concentrated Portfolio Open Shares (LEVOX)
Unlock premium access to view the live fair value comparison against current market price for LEVOX.
Frequently Asked Questions - LEVOX
How is LEVOX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for LEVOX.
Is LEVOX undervalued or overvalued right now?
LEVOX is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for LEVOX: open their intrinsic value pages.
- BMDSXBaird Mid Cap Growth Fund - Investor Class
- BAUAXBrown Advisory Small-Cap Fundamental Value Fund Advisor Shs
- BOSOXBoston Trust Walden Small Cap Fund
- EEni S.p.A.
- LEVIXLazard US Equity Concentrated Portfolio
- SFAAXAllspring Index Asset Allocation Fund Class A
- LLoews Corporation
- ARTTXArtisan Focus Fund Investor Shares